This study reviewed 15,895 intravitreal injections (9453 ranibizumab, 5386 bevacizumab, 935 triamcinolone, and 121 pegaptanib) that were performed for various indications over a 5-year period. Of the ...

There has been dramatic growth in the number of intravitreal injections performed annually. This paper features expert panel consensus regarding the use of intravitreal injections and serves as an ...

More than 60% of tarcocimab-treated patients had reduced severity ...

After a single intravitreal dose of 4D-150, visual acuity and anatomic control was maintained with consistent and durable treatment burden ...

Patients completed a questionnaire that assessed the impact of intravitreal injections on quality of life This article is part of MPR’s coverage of the American Academy of Ophthalmology 2019 Meeting, ...

Please provide your email address to receive an email when new articles are posted on . An expert panel that was convened to update guidelines for giving intravitreal injections makes clear that ...

A low risk of adverse safety outcomes was observed in anti–vascular endothelial growth factor (VEGF) intravitreal injections performed in office-based and operating room settings, with a higher rate ...

A history of multiple past intravitreal injections (IVIs) poses a risk for certain future cataract surgery complications, according to a study presented at the annual meeting of the American Academy ...

Please provide your email address to receive an email when new articles are posted on . I believe intravitreal injections are best performed in the office for many reasons. First of all, it is safe.

Similar results in patients who had port delivery system for 4 years or switched after 64 ...